Boston Scientific Announces Nalu Medical Acquisition to Expand Chronic‑Pain Portfolio
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement...
NYSE: BSX
Boston Scientific’s FARAPULSE Gains FDA Approval for Expanded Use in Persistent Atrial Fibrillation
US-based Boston Scientific Corporation (NYSE: BSX) announced that it has received US FDA approval for...
Boston Scientific Reports 20.9% Revenue Growth in Q1 2025 Financial Results
US medical technology giant Boston Scientific Corporation (NYSE: BSX) released its Q1 2025 financial report,...
Boston Scientific to Acquire SoniVie, Boosting Hypertension Treatment Portfolio
Boston Scientific Corporation (NYSE: BSX) is set to acquire SoniVie Ltd, an Israel-based medical device...
Boston Scientific Posts Strong Q4 and Full-Year 2024 Results
Boston Scientific Corporation (NYSE: BSX) released its Q4 and full-year 2024 financial report, showing robust...
Boston Scientific’s FARAPULSE and WATCHMAN FLX Studies Show Positive Results
US major Boston Scientific Corporation (NYSE: BSX) has announced the presentation of positive results from...
Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million
US major Boston Scientific Corporation (NYSE: BSX) is set to acquire Bolt Medical, Inc., a...
Boston Scientific Launches Athletis Peripheral Balloon Dilatation Catheter in China
US-based medical device leader Boston Scientific Corporation (NYSE: BSX) has announced the market launch of...
Boston Scientific’s Next-Gen IVUS System AVVIGO+ Approved by China’s NMPA for Coronary Disease Use
US-based Boston Scientific Corporation (NYSE: BSX) has announced that China’s National Medical Products Administration (NMPA)...
Boston Scientific Corporation to Acquire Intera Oncology Inc., Expanding Cancer Treatment Portfolio
US-based medical device giant Boston Scientific Corporation (NYSE: BSX) has announced a definitive acquisition agreement...
Boston Scientific Expands Neuromodulation Portfolio with Axonics Acquisition
Boston Scientific Corporation (NYSE: BSX), a leading player in the medical device industry, has announced...
Boston Scientific Launches Vercisie Genius DBS System in China for Parkinson’s Disease Treatment
US major Boston Scientific Corporation (NYSE: BSX) has officially launched its Vercisie Genius, an implantable...
Boston Scientific Corporation Announces Acquisition of Cortex, Inc.
US-based medical device giant Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement...
Boston Scientific Reports 19.5% YOY Increase in Q3 Net Sales, Driven by New Product Launches and Market Expansion
Boston Scientific Corporation (NYSE: BSX), a leading medical device manufacturer in the U.S., has announced...
Advancing Peripheral Artery Disease Care: Boston Scientific’s JETSTREAM Receives Marketing Nod in China
NEW YORK—Boston Scientific Corporation (NYSE: BSX), a leading innovator in medical solutions, has secured a...
Boston Scientific Secures Silk Road Medical in a $1.16B Deal to Fortify Stroke Prevention Portfolio
Boston Scientific Corporation (NYSE: BSX), a leading innovator in medical devices, has announced a definitive...
Boston Scientific’s FARAPULSE Pulse Field Ablation System Earns NMPA Approval
Boston Scientific Corporation (NYSE: BSX), a leading medical device company in the U.S., has announced...
Cryofocus Medtech Partners with Boston Scientific for Respiratory Products Distribution in China
Cryofocus Medtech (Shanghai) Co., Ltd. (HKG: 6922), a Shanghai-based specialist in cryoablation treatment, has announced...
Boston Scientific Gets NMPA Approval for Agent DCB, First of Its Kind for Coronary ISR Treatment
Boston Scientific Corporation (NYSE: BSX), a leading medical device manufacturer in the U.S., has announced...
Acotec Scientific and Boston Scientific Announce Comprehensive Collaboration Agreement
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a cooperation framework and service framework...